Laboratory – Center for high-tech medical diagnosis Thien Nhan Danang has enough capacity to confirm positive for Sars-CoV-2. Today, April 26, Dr. Do Thai Hung, Director of Nha Trang Pasteur Institute signed Decision No. 905 / QD-IPN on recognition of the laboratory – Center for high-tech medical diagnosis Thien Nhan Da Nang. confirmation of SARS-CoV-2 virus positive cases. This laboratory is responsible for confirming cases of positive for SARS-CoV-2 virus in Da Nang, to confirm for other localities upon request and report test data according to regulations. . Earlier on April 24, Nha Trang Pasteur Institute conducted an inspection and assessment of the testing capacity for SARS-CoV-2 virus of Thien Nhan Laboratory – Thien Nhan, Thien Nhan High-tech Medical Diagnostic Center in Da Nang. . Thien Nhan Da Nang High-Tech Medical Diagnostic Center has built a molecular biology laboratory according to international association standards, ensuring accuracy and safety in the process of receiving and manipulating tests. Sample / Solution Transport … Nha Trang Pasteur Institute has verified and recognized all the operating documents / procedures, equipment management, initial waste treatment in medical waste treatment, general testing procedures. test; fully equipped with chemicals, biologicals and materials for the SARS-CoV-2 confirmation test. In particular, people who test positive cases for SARS-CoV-2 virus meet the prescribed requirements, are well trained in screening testing techniques trained by Nha Trang Pasteur Institute. According to Mr. Ngo Duc Hai, Director of Thien Nhan High-tech Medical Diagnostic Center, is the first private medical unit in Da Nang to be licensed by the Department of Health of Da Nang City to coordinate the City Disease Control Center. Da Nang (CDC) tested for SARS-CoV-2 from August 2020. Over the past time, Thien Nhan laboratory has tested SARS-CoV-2 for more than 8,000 people, actively serving the Covid-19 epidemic prevention and control of Da Nang city and central provinces. Especially during the peak epidemic in Da Nang 8-2020, to meet the needs of safety in production, travel, exit … in accordance with regulations on prevention and control of Covid-19 epidemic. Thien Nhan hopes to contribute more to the proactively coping with the increasingly complicated Covid-19 epidemic in the world, serving the safety of production, travel, study and work of the people. local at home and abroad.

The content of strategic cooperation between the Central Institute of Hematology – Blood Transfusion and Roche Vietnam includes the following main activities: Organize specialized training programs and conferences to improve the capacity and experience of health workers in the care and treatment of hematological diseases; Support and connect the Central Institute of Hematology and Blood Transfusion to approach and participate in cooperation activities with agencies and organizations in Vietnam as well as internationally with the aim of learning and sharing treatment experiences from domestic and foreign experts and specialized centers; Organize activities aimed at patients and the community to propagate and raise awareness about diagnosis and treatment, focusing on hemophilia and non-Hodgkin lymphoma. The Central Institute of Hematology and Blood Transfusion in collaboration with Roche Vietnam organized a memorandum of understanding TS. BS. Bach Quoc Khanh, Director of the Central Institute of Hematology – Blood Transfusion, said: “We always support all the cooperation and support of prestigious organizations in the world for the development of Vietnamese health. , all for the goal of bringing better quality of treatment for patients who unfortunately suffer from blood clotting disorders and malignant blood diseases ”. Mr. Girish Mulye, General Director of Roche Pharma Vietnam emphasized: “Combining Roche’s global strengths and innovative solutions with expertise with the dedication and expertise from the medical team, we wishes to give more opportunities to those unlucky people suffering from this incurable disease. This is also part of the company’s long-term commitment to public health in reducing mortality caused by this group of diseases ”. Hemophila (also known as hemophilia) is an inherited bleeding disease caused by decreased or abnormal function of clotting factor VIII / IX. It is estimated that in Vietnam, there are more than 6,200 people with hemophilia, of which nearly 40% of the patients have not been diagnosed and treated. Non-Hodgkin’s lymphoma is another malignancy that tends to increase rapidly among the elderly in Vietnam, especially in men. In 2018, Vietnam had more than 3,500 new cases and more than 2,100 deaths, ranking 14th in terms of incidence rates among cancers. Like other hematological diseases, Hemophila and non-Hodgkin lymphoma cannot be completely cured, but if detected early and responded well to treatment, patients can still maintain their health and live almost life. normal. The Memorandum of Understanding between the Central Institute of Hematology – Blood Transfusion and Roche Vietnam is expected to be implemented within a year and will be in operation from April 2021. Through domestic and foreign cooperation, this strategic cooperation is expected to bring about many positive changes, helping to strengthen the capacity for hematological care and treatment.

Ms. Catherine DEROCHE, Chairman of the Committee of Social Affairs of the French Senate, is also the Chairman of the Franco-Vietnam Friendship Senate Group in the Senate.

Reporter: The new Prime Minister of Vietnam, Mr. Pham Minh Chinh, used to be the leader of a locality with an important position in Vietnam economically. In your opinion, what are the advantages for the development of cooperation between the two countries?

Ms. Catherine DEROCHE: I believe that, when selected, Mr. Pham Minh Chinh has the necessary strengths. Local potential and wealth is an important spearhead. With deep economic knowledge and understanding of localities, he will be a good middleman for the cooperation relationship between localities of Vietnam and France. Currently, there are many localities in Vietnam having cooperation relations with localities in France.

Reporter: How do you evaluate the strategic partnership between Vietnam and France, especially the role of Vietnam in the French strategy in the Indo-Pacific region?

Ms. Catherine DEROCHE: Vietnam plays an important role in the Indo-Pacific. The Indo-Pacific is also a strategically important region for France. France wants to consolidate a foothold in this region. Vietnam is an important partner in our strategy here.

We aim to ensure peace and stability in the region, while at the same time guarantee freedom of navigation, respect for international law. With its increasingly important role in the Association of Southeast Asian Nations (ASEAN) and its pace of development, it is undeniable that Vietnam is a particularly important partner of France in this region.

Reporter: How do you assess Vietnam’s achievements in recent years, especially its success in the fight against the COVID-19 pandemic?

Ms. Catherine DEROCHE: For the COVID-19 pandemic, Vietnam is an example because Vietnam has successfully implemented a strategic strategy since the outbreak of the epidemic, which has been recognized by international organizations. This was indeed an admiration but also a great surprise. How has a country like Vietnam overcome the pandemic, unlike many other countries. To date, only a few thousand viral infections have been recorded, with few deaths. The vaccination campaign has also been implemented very quickly. I think this is a very remarkable management approach.

Meanwhile, the slow, slow awareness of the epidemic, the slow implementation of the bureaucracy made us face problems with masks, testing, the vaccination campaign started but late. France as well as other European countries did not adopt a suitable strategy. In France, we have never been able to isolate the infected person, then proceed to trace, the decision to close the border was made too slow.

Countries like Vietnam adopt a “no virus infection” strategy, while we cannot. /.

Reporter: Would like to thank you so much!./.